Guangdong Marubi Biotechnology Co.,Ltd.’s Net Profit Rose 22.9% in First Quarter of 2023

Guangdong Marubi Biotechnology Co.,Ltd. (广东丸美生物技术股份有限公司) (603983.SH) reported a net profit of 78.9 million yuan in the first quarter of 2023, up 22.9% year-on-year.

Meanwhile, the company posted 476.7 million yuan in revenue, up 24.6% year-on-year.

At the end of the reporting period, it had 4.2 billion yuan in total assets and 826.2 million yuan in total liabilities, with a liability-to-asset ratio of 19.9%.